NNIT is pleased to announce its role as a strategic implementation partner for Eirgen Pharma’s new Electronic Batch Record (EBR) system, internally referred to as Project Elevate. This initiative is a cornerstone of Eirgen’s digital transformation strategy and marks a decisive shift away from manual, paper-based batch documentation toward a fully digitized, real-time operational environment. The s
The integration of NNIT Group Company SL Controls was initiated in May, and plans are in place for completion by year-end 2024.
After more than 14 years at the same location in Switzerland, NNIT has relocated to Grosspeter Tower, an impressive 21-storey structure in the city of Basel.
The life sciences market in Europe is idling – even hesitant – following the macro-economic and geo-political hits of war, energy crisis, inflation, increasing interest rates and increasing EU regulation. But Ricco Larsen, Senior Vice President of Life Sciences Europe at NNIT, remains positive based on a firm belief in the resilience of the industry.
Revenue growth of 12.2%, an operating profit margin of 5.2% – and full-year financial outlook maintained.
A new global structure dedicated to AI and led by Director Sam Laermans has been created to ensure unity, best practice, and maximum utilization of expertise and resources across our four regional AI business units.
More than 400 talented and ambitious young people were nominated for this year's Talent 100 published by Berlingske. Only 100 talents were ultimately selected for this year’s list, and Marina Prodan is one of them.
Nearly half of the respondents in NNIT’s Expectation Barometer 2023 survey place heightened integration of AI at the top of their priority list. However, prior to fully embracing AI, life sciences companies should prioritize the people and business processes that will become AI’s closest allies.
Like the rest of the world, the life sciences industry is right in the eye of a raging storm of multiple rapid changes. According to Ricco Larsen, Senior Vice President at NNIT, the top priority for pharma companies is to invest in a solid data foundation so they are fully prepared for what comes next.
The potential benefits of an electronic Trial Master File (eTMF) system extend far beyond clinical operations. As Tróndur Ellingsgaard, Advisory Consultant at NNIT explains, a mature eTMF can enhance efficiency, foster greater collaboration across the organization, and enable informed decision-making.
Everest Group has just released its Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024 (part of the Life Sciences Information Technology research program), and we are proud to announce that NNIT features among the Leaders.
Life science organizations face complex regulatory challenges, intensive audits, and robust internal process controls. With this new partnership, NNIT and Gimmal provide a well-established, compliant solution that customers operating within life sciences can rely on to manage the information lifecycle of GxP records.
As NNIT expands its presence in the United States, particularly with the anticipated integration of Excellis Health Solutions (Excellis), Greg Cathcart, Head of Excellis, will assume the lead role of Senior Vice President to accelerate growth and advance the market position in the US.
Implementing an electronic Trial Master File (eTMF) system can revolutionize the way clinical trials are managed. However, as Michael Agard, Director of Clinical Consulting at NNIT, points out, the true value of eTMF lies in post-implementation management.
The backbone of every clinical trial is undergoing an inevitable digital revolution. Klaudia Markowski, Senior Business Consultant at NNIT, explains why the appropriate time to implement an electronic Trial Master File (eTMF) might be sooner than you think.
As of October 10, 2022, Valiance® has been fully integrated with NNIT. All employees and business activities have been merged into the appropriate NNIT subsidiaries in Europe and the US.
NNIT, a trusted partner of AstraZeneca’s since 2014, will be implementing the critical COVID-19 vaccine post-marketing safety data system.
Vi bad Jesper Borgstrøm, Advanced Advisory Consultant, i NNIT Life Sciences – Regulatory Affairs, om at guide os gennem de sikkerhedsprocedurer, der gælder for en af verdens mest regulerede produktudviklings og -produktionsprocesser.
We asked Jesper Borgstrøm, Advanced Advisory Consultant, NNIT Life Sciences – Regulatory Affairs, to take us through the safety aspects of one of the world’s most regulated product development and manufacturing processes.
